Stay updated on SAGE-217 for MDD Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-217 for MDD Relapse Prevention Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T15:48:44.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide NIH announcement explains the transition to using “Super Intelligence” instead of “Artificial Intelligence” and points visitors to transition updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-25T15:44:01.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T22:22:33.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:20:17.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new platform revision entry v3.7.0 was added to the record history, replacing the previous v3.6.6. This indicates an update to the versioning or UI of the history log.
    Difference
    0.1%
    Check dated 2026-09-20T22:31:04.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    - The record history now shows the latest release entry (v3.6.6) replacing v3.6.5, reflecting an update to the page's version history.
    Difference
    0.1%
    Check dated 2026-08-30T15:53:58.000Z thumbnail image

Stay in the know with updates to SAGE-217 for MDD Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.